About AxTalis
AxTalis is a company based in Gentbrugge (Belgium) founded in 2020 by Frank Vanderdonck was acquired by Kester Capital in May 2024. AxTalis offers products and services including Regulatory Compliance, Medical Affairs, and Market Access - HEOR. AxTalis operates in a competitive market with competitors including Heartland Dental, AOK, Keplr Vision, The Chartis Group and Sterigenics, among others.
- Headquarter Gentbrugge, Belgium
- Founders Frank Vanderdonck
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Jurisdiction Bangalore North, Karnataka, India
-
Annual Revenue
$403.09 K (USD)19.31as on Mar 31, 2022
-
Net Profit
$26.11 K (USD)-14.87as on Mar 31, 2022
-
EBITDA
$31.2 K (USD)28.43as on Mar 31, 2022
-
Latest Funding Round
Not available
- Investors
-
Employee Count
Not available
-
Acquired by
Kester Capital
(May 21, 2024)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of AxTalis
AxTalis offers a comprehensive portfolio of products and services, including Regulatory Compliance, Medical Affairs, and Market Access - HEOR.
Provides strategic advice for healthcare compliance and lifecycle management
Offers leadership for medical strategy and opportunity identification
Supports health economics and early stakeholder dialogues for access
People of AxTalis
Unlock access to complete
Funding Insights of AxTalis
Detailed funding history for AxTalis
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in AxTalis
AxTalis has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Kester Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Kester Capital is focused on private equity investments in technology and life sciences sectors.
|
Locked | Locked | Locked |
Investor details for AxTalis
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by AxTalis
Investment portfolio details for AxTalis
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - AxTalis
Detailed financials for AxTalis
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Axtalis Comparisons
Peer comparison for AxTalis
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of AxTalis
AxTalis operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Heartland Dental, AOK, Keplr Vision, The Chartis Group and Sterigenics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Provider of healthcare consulting services
|
|
| Locked | Locked | Locked |
Medical insurance services for patients and employees are provided.
|
|
| Locked | Locked | Locked |
Business support and supply chain management services are offered.
|
|
| Locked | Locked | Locked |
Advisory services are offered to U.S. healthcare providers.
|
|
| Locked | Locked | Locked |
Provider of comprehensive sterilization solutions and expert consulting services
|
|
| Locked | Locked | Locked |
Contract manufacturing is provided for life sciences and diagnostics reagents.
|
Detailed competitors of AxTalis
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Axtalis
Complete news archive for AxTalis
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about AxTalis
AxTalis was founded in 2020.
AxTalis is headquartered in Gentbrugge, Belgium. It is registered at Gentbrugge, East Flanders, Belgium.
Frank Vanderdonck is the current CEO of AxTalis. They have also founded this company.
Annual revenue of AxTalis is $403.09K as on Mar 31, 2022.
AxTalis was founded in 2020 as a consultancy serving the pharmaceutical and medical device sectors. Assistance is offered in regulatory affairs, market access, and medical affairs. The firm is headquartered in Gentbrugge, Belgium, with operations covering Belgium, the Netherlands, and Luxembourg. Core services address compliance, reimbursement strategies, and scientific communication needs within these industries.
AxTalis's top competitors include Qualicorp, Heartland Dental and Argonautms.
AxTalis offers Regulatory Compliance, Medical Affairs, and Market Access - HEOR.
AxTalis has 1 investor. Key investors include Kester Capital.